Diclofenac sodium transdermal patch (Hisamitsu Pharmaceuticals)

双氯芬酸钠透皮贴剂(久光制药)

Report date: 2025/03/04 10:07:17

Base Information

Drug NameDiclofenac sodium transdermal patch (Hisamitsu Pharmaceuticals)
Drug Alias NameHSP-3150HP-3150HP-5000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsCancer PainBack PainPain +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCancer PainBack PainPain
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A